Cargando…
Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis
Despite the availability of advanced multimodal therapy, the prognosis of patients suffering from glioblastoma (GBM) remains poor. We conducted a genome-wide integrative analysis of mRNA expression profiles in 302 GBM tissues and 209 normal brain tissues from the Gene Expression Omnibus (GEO), The C...
Autores principales: | Xu, Huifang, Zhang, Linfang, Xia, Xiujuan, Shao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305328/ https://www.ncbi.nlm.nih.gov/pubmed/35873480 http://dx.doi.org/10.3389/fgene.2022.931938 |
Ejemplares similares
-
Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020) -
A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
por: Liu, Zhentao, et al.
Publicado: (2021) -
Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development
por: Ye, Liguo, et al.
Publicado: (2021) -
Identification of a five‐mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor
por: Lin, Xiao‐Dan, et al.
Publicado: (2019) -
Identification of mRNA Signature for Predicting Prognosis Risk of Rectal Adenocarcinoma
por: Jiang, Linlin, et al.
Publicado: (2022)